Indexed in Journament

cardiovascular diabetology

ISSN 1475-2840· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
37.0 / 100
Journament Score
Poor
Ranked #6,214 of 29,324 scored journals (33,995 indexed)
89 Articles
Scores higher than 78.8% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name cardiovasc diabetol
Abbreviated Name cardiovascular diabetology
ISSN 1475-2840
URL http://www.cardiab.biomedcentral.com

Quality Profile

7 of 12 dimensions measured
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.

Show the numbers
Dimension This journal Corpus average
Engagement 30.7 30.4
Accessibility 20.0 19.1
Timeliness 0.0 9.2
Diversity 55.6 25.8
Innovation 70.0 27.4
Community Impact 12.1 7.8
Content Distribution 62.1 88.6
Content Quality — 55.5
Ethics & Transparency — 40.2
Editorial Standards — 33.4
Publication Regularity — 53.2
Geographic Reach — 30.8

Publications Per Year

Articles (89)

2015
complete pathologic response as a prognostic factor for squamous cell carcinoma of the oropharynx post-chemoradiotherapy
;Damila Cristina Trufelli;Leandro Luongo de Matos;Thaiana Aragão Santana;Fábio de Aquino Capelli;Jossi Ledo Kanda;Auro Del Giglio;Gilberto de Castro Junior
Vol. 81 , No. 5 , pp. 498-504
559 views DOI Abstract
2009
YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
Camilla, Rathcke;Henrik, Vestergaard;
Vol. 8 , No. 1 , pp. 61-
522 views Abstract
2018
Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report
Matsutani, Daisuke;Sakamoto, Masaya;Iuchi, Hiroyuki;Minato, Souichirou;Suzuki, Hirofumi;Kayama, Yosuke;Takeda, Norihiko;Horiuchi, Ryuzo;Utsunomiya, Kazunori;
Vol. 17 , No. 1 , pp. 1-11
503 views Abstract
2019
Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study.
Shao, Shih-Chieh;Chang, Kai-Cheng;Hung, Ming-Jui;Yang, Ning-I;Chan, Yuk-Ying;Chen, Hui-Yu;Kao Yang, Yea-Huei;Lai, Edward Chia-Cheng;
Vol. 18 , No. 1 , pp. 120
461 views DOI Abstract
2016
auditory evoked potentials in a newborn wistar rat model of hyperbilirubinemia
;Çagil Gökdogan;Aydan Genç;Özlem Gülbahar;Ozan Gökdogan;Ayse Helvaci;Selin Üstün Bezgin;Leyla Memis
Vol. 82 , No. 2 , pp. 144-150
404 views DOI Abstract
2019
Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study.
Yan, Yinkun;Li, Shengxu;Liu, Yang;Bazzano, Lydia;He, Jiang;Mi, Jie;Chen, Wei;
Vol. 18 , No. 1 , pp. 109
401 views DOI Abstract
2005
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study
Christian, Berne;Annica, Siewert-Delle;
Vol. 4 , No. 1 , pp. 7-
392 views Abstract
2012
papel da punção do seio maxilar no diagnóstico e no tratamento de pacientes com rinossinusite hospitalar the role of maxillary sinus puncture on the diagnosis and treatment of patients with hospital-acquired rhinosinusitis
;José Arruda Mendes Neto;Viviane Maria Guerreiro;Elcio Roldan Hirai;Eduardo Macoto Kosugi;Rodrigo de Paula Santos;Luis Carlos Gregório
Vol. 78 , No. 4 , pp. 35-41
378 views DOI Abstract
2017
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
Tanaka, Atsushi;Shimabukuro, Michio;Okada, Yosuke;Taguchi, Isao;Yamaoka-Tojo, Minako;Tomiyama, Hirofumi;Teragawa, Hiroki;Sugiyama, Seigo;Yoshida, Hisako;Sato, Yasunori;Kawaguchi, Atsushi;Ikehara, Yumi;Machii, Noritaka;Maruhashi, Tatsuya;Shima, Kosuke R.;Takamura, Toshinari;Matsuzawa, Yasushi;Kimura, Kazuo;Sakuma, Masashi;Oyama, Jun-ichi;Inoue, Teruo;Higashi, Yukihito;Ueda, Shinichiro;Node, Koichi;Investigators, On Behalf of the EMBLEM Trial;
Vol. 16 , No. 1 , pp. 1-12
373 views Abstract
2011
Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
Butalia, Sonia;Leung, Alexander A;Ghali, William A;Rabi, Doreen M;
Vol. 10 , pp. 25
351 views DOI Abstract
2019
New dual peroxisome proliferator activated receptor agonist - Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: Integrated analysis of the real world evidence
Kaul, U.
Vol. 18 , pp. 0-0
312 views DOI
2019
Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study.
Shao, Shih-Chieh;Chang, Kai-Cheng;Hung, Ming-Jui;Yang, Ning-I;Chan, Yuk-Ying;Chen, Hui-Yu;Kao Yang, Yea-Huei;Lai, Edward Chia-Cheng;
Vol. 18 , No. 1 , pp. 120
461 views DOI Abstract
2019
Temporal relationship between inflammation and insulin resistance and their joint effect on hyperglycemia: the Bogalusa Heart Study.
Yan, Yinkun;Li, Shengxu;Liu, Yang;Bazzano, Lydia;He, Jiang;Mi, Jie;Chen, Wei;
Vol. 18 , No. 1 , pp. 109
401 views DOI Abstract
2018
Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report
Matsutani, Daisuke;Sakamoto, Masaya;Iuchi, Hiroyuki;Minato, Souichirou;Suzuki, Hirofumi;Kayama, Yosuke;Takeda, Norihiko;Horiuchi, Ryuzo;Utsunomiya, Kazunori;
Vol. 17 , No. 1 , pp. 1-11
503 views Abstract
2017
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
Tanaka, Atsushi;Shimabukuro, Michio;Okada, Yosuke;Taguchi, Isao;Yamaoka-Tojo, Minako;Tomiyama, Hirofumi;Teragawa, Hiroki;Sugiyama, Seigo;Yoshida, Hisako;Sato, Yasunori;Kawaguchi, Atsushi;Ikehara, Yumi;Machii, Noritaka;Maruhashi, Tatsuya;Shima, Kosuke R.;Takamura, Toshinari;Matsuzawa, Yasushi;Kimura, Kazuo;Sakuma, Masashi;Oyama, Jun-ichi;Inoue, Teruo;Higashi, Yukihito;Ueda, Shinichiro;Node, Koichi;Investigators, On Behalf of the EMBLEM Trial;
Vol. 16 , No. 1 , pp. 1-12
373 views Abstract
2016
auditory evoked potentials in a newborn wistar rat model of hyperbilirubinemia
;Çagil Gökdogan;Aydan Genç;Özlem Gülbahar;Ozan Gökdogan;Ayse Helvaci;Selin Üstün Bezgin;Leyla Memis
Vol. 82 , No. 2 , pp. 144-150
404 views DOI Abstract
2015
papillary thyroid carcinoma: does the association with hashimoto's thyroiditis affect the clinicopathological characteristics of the disease?
;Fábio Muradás Girardi;Marinez Bizarro Barra;Cláudio Galleano Zettler
Vol. 81 , No. 3 , pp. 283-287
195 views DOI Abstract
2015
effects of vibrotactile vestibular substitution on vestibular rehabilitation - preliminary study,
;Cibele Brugnera;Roseli Saraiva Moreira Bittar;Mário Edvin Greters;Dietmar Basta
Vol. 81 , No. 6 , pp. 616-621
306 views DOI Abstract
2015
review of survival rates 20-years after conservative surgery for papillary thyroid carcinoma
;Abrão Rapoport;Otávio Alberto Curioni;Ali Amar;Rogério Aparecido Dedivitis
Vol. 81 , No. 4 , pp. 389-393
211 views DOI Abstract
2015
waldenström's macroglobulinemia presenting with bilateral vestibular loss: a case report
;Andrea Castellucci;Gianluca Piras;Cristina Brandolini;Giovanni Carlo Modugno;Gian Gaetano Ferri
Vol. 81 , No. 5 , pp. 571-575
179 views DOI
Journament Score
37.0/100 · Poor
Ranked #6,214 of 29,324 scored
(33,995 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

37.0/100

Tier: Poor

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

30.7/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

20.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

55.6/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

70.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

12.1/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

0.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

62.1/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.